1
|
Vinnikov V, Belyakov O. Clinical Applications of Biological Dosimetry in Patients Exposed to Low Dose Radiation Due to Radiological, Imaging or Nuclear Medicine Procedures. Semin Nucl Med 2021; 52:114-139. [PMID: 34879905 DOI: 10.1053/j.semnuclmed.2021.11.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
Radiation dosimetric biomarkers have found applications beyond radiation protection area and now are actively introduced into clinical practice. Cytogenetic assays appeared to be a valuable tool for individualized quantifying radiation effects in patients, with high capability for assessing genotoxicity of various medical exposure modalities and providing meaningful radiation dose estimates for prognoses of radiation-related cancer risk. This review summarized current data on the use of biological dosimetry methods in patients undergoing various medical irradiations to low doses. The highlighted topics include basic aspects of biological dosimetry and its limitations in the range of low radiation doses, and main patterns of in vivo induction of radiation biomarkers in clinical exposure scenarios, occurring in X-ray diagnostics, computed tomography, interventional radiology, low dose radiotherapy, and nuclear medicine (internally administered 131I and other radiopharmaceuticals). Additionally, several specific issues, examined by biodosimetry techniques, are analysed, such as contrast media effect, radiation response in pediatric patients, impact of magnetic resonance imaging, evaluation of radioprotectors, detection of patients' abnormal intrinsic radiosensitivity and dose estimation in persons involved in medical radiation incidents. A prognosis of possible directions for further improvements in this area includes the automation of cytogenetic analysis, introduction of molecular biodosimeters and development of multiparametric biodosimetry platforms. A potential approach to the advanced biodosimetry of internal exposure and/or low dose external irradiation is suggested; this can be a multiparametric platform based on the combination of the γ-H2AX foci, dicentric, and translocation assays, each applied in the optimum postexposure time range, with the amalgamation of the dose estimates. The study revealed the necessity of further research, which might clarify medical radiation safety concerns for patients via using stringent biodosimetry methodology.
Collapse
Affiliation(s)
- Volodymyr Vinnikov
- International Atomic Energy Agency (IAEA), Vienna, Austria; Grigoriev Institute for Medical Radiology and Oncology (GIMRO), Kharkiv, Ukraine.
| | - Oleg Belyakov
- International Atomic Energy Agency (IAEA), Vienna, Austria
| |
Collapse
|
2
|
Jalali AH, Mozdarani H, Ghanaati H. The Effect of Contrast Enhanced Abdominopelvic Magnetic Resonance Imaging on Expression and Methylation Level of ATM and AKT Genes. CELL JOURNAL 2021; 23:335-340. [PMID: 34308577 PMCID: PMC8286456 DOI: 10.22074/cellj.2021.7258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/06/2019] [Accepted: 12/28/2019] [Indexed: 11/12/2022]
Abstract
Objective To evaluate the effect of contrast enhanced abdominopelvic magnetic resonance imaging (MRI), using a 3 Tesla
scanner, on expression and methylation level of ATM and AKT genes in human peripheral blood lymphocytes. Materials and Methods In this prospective in vivo study, blood samples were obtained from 20 volunteer patients with mean
age of 43 ± 8 years (range 32-68 years) before contrast enhanced MRI, 2 hours and 24 hours after contrast enhanced abdominopelvic
3 Tesla MRI. After separation of mononuclear cells from peripheral blood, using Ficoll-Hypaque, we analyzed gene expression
changes of ATM and AKT genes 2 hours and 24 hours after MRI using quantitative reverse transcription polymerase chain reaction
(qRT-PCR). We also evaluated methylation percentage of the above mentioned genes in before, 2 hours and 24 hours after MRI,
using MethySYBR method.
Results Fold change analysis, in comparison with the baseline, respectively showed 1.1 ± 0.7 and 0.8 ± 0.5 mean of gene
expressions in 2 and 24 hours after MRI for ATM, while the results were 1.4 ± 0.6 and 1.4 ± 1 for AKT (P>0.05). Methylation of
the ATM gene promoter were 8.8 ± 1.5%, 9 ± 0.6% and 9 ± 0.8% in before contrast enhanced MRI, 2 and 24 hours after contrast
enhanced MRI, respectively (P>0.05). Methylation of AKT gene promoter in before contrast enhanced MRI, 2 hours and 24 hours
after contrast enhanced MRI was 5.4 ± 2.5, 5 ± 3.2, 4.9 ± 2.9 respectively (P>0.05). Conclusion Contrast enhanced abdominopelvic MRI using 3 Tesla scanner apparently has no negative effect on the expression
and promoter methylation level of ATM and AKT genes involved in the repair pathways of genome.
Collapse
Affiliation(s)
- Amir Hossein Jalali
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | - Hossein Mozdarani
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
| | - Hossein Ghanaati
- Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
3
|
Jalali AH, Mozdarani H, Ghanaati H. The genotoxic effects of contrast enhanced abdominopelvic 3-tesla magnetic resonance imaging on human circulating leucocytes. Eur J Radiol 2020; 129:109037. [PMID: 32446124 DOI: 10.1016/j.ejrad.2020.109037] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2019] [Revised: 03/16/2020] [Accepted: 04/22/2020] [Indexed: 11/29/2022]
Abstract
PURPOSE To evaluate the effects of contrast enhanced abdominopelvic magnetic resonance imaging (MRI) on DNA damage. METHODS For this study, blood samples of 20 volunteers (15 women and 5 men) with mean age of 43 ± 8 years were assessed. The mean age of women was 41.4 ± 8.9 years and mean age of men was 48.5 ± 4.9 years (P = 0.14). Peripheral blood samples were collected before, 2 and 24 h after MRI in heparin and ethylenediaminetetraacetic acid (EDTA) containing tubes. Heparinized blood was cultured to assess the cytogenetic effects using cytokinesis blocked micronucleus (CBMN) assay. After isolation of mononuclear cells, alterations in genes involved in repair (CHEK2, p21) and apoptosis (BAX, BCL2) were analyzed using real-time polymerase chain reaction (qRT-PCR). RESULTS The mean number of MN in binucleated cells at before, 2 and 24 h after MRI were 17.9 ± 2.9, 18.1 ± 2.4 and 18.3 ± 2.6, respectively (p > 0.05). Results of gene expression according to fold change compared with the baseline were 1.2 ± 0.6 and 1.02 ± 0.5 at 2 and 24 h after MRI for CHEK2, and 1.3 ± 0.7 and 1.7 ± 0.7 for CDKN1A (p21); respectively (p > 0.05). Gene expression based on fold change compared with baseline were 0.9 ± 0.6 and 1.2 ± 0.8 at 2 and 24 h after MRI for BAX, and 1.05 ± 0.3 and 1.1 ± 0.7 for BCL2; respectively (p > 0.05). CONCLUSION Contrast enhanced abdominopelvic MRI showed no adverse effect on DNA in terms of MN formation and alterations in expression levels of some genes involved in repair and apoptosis pathways.
Collapse
Affiliation(s)
- Amir Hossein Jalali
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
| | - Hossein Mozdarani
- Department of Medical Genetics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
| | - Hossein Ghanaati
- Advanced Diagnostic and Interventional Radiology Research Center, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
4
|
Wilén J, Olsrud J, Frankel J, Hansson Mild K. Valid Exposure Protocols Needed in Magnetic Resonance Imaging Genotoxic Research. Bioelectromagnetics 2020; 41:247-257. [PMID: 32157722 DOI: 10.1002/bem.22257] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2019] [Accepted: 02/22/2020] [Indexed: 11/10/2022]
Abstract
Several in vitro and in vivo studies have investigated if a magnetic resonance imaging (MRI) examination can cause DNA damage in human blood cells. However, the electromagnetic field (EMF) exposure that the cells received in the MR scanner was not sufficiently described. The first studies looking into this could be regarded as hypothesis-generating studies. However, for further exploration into the role of MRI exposure on DNA integrity, the exposure itself cannot be ignored. The lack of sufficient method descriptions makes the early experiments difficult, if not impossible, to repeat. The golden rule in all experimental work is that a study should be repeatable by someone with the right knowledge and equipment, and this is simply not the case with many of the recent studies on MRI and genotoxicity. Here we discuss what is lacking in previous studies, and how we think the next generation of in vitro and in vivo studies on MRI and genotoxicity should be performed. Bioelectromagnetics. © 2020 Bioelectromagnetics Society.
Collapse
Affiliation(s)
- Jonna Wilén
- Department of Radiation Sciences, Radiation Physics, Umeå University, Umeå, Sweden
| | - Johan Olsrud
- Department of Diagnostic Radiology, Skåne University Hospital, Lund University, Lund, Sweden
| | - Jennifer Frankel
- Department of Radiation Sciences, Radiation Physics, Umeå University, Umeå, Sweden
| | - Kjell Hansson Mild
- Department of Radiation Sciences, Radiation Physics, Umeå University, Umeå, Sweden
| |
Collapse
|
5
|
Critchley WR, Reid A, Morris J, Naish JH, Stone JP, Ball AL, Major T, Clark D, Waldron N, Fortune C, Lagan J, Lewis GA, Ainslie M, Schelbert EB, Davis DM, Schmitt M, Fildes JE, Miller CA. The effect of 1.5 T cardiac magnetic resonance on human circulating leucocytes. Eur Heart J 2019; 39:305-312. [PMID: 29165554 DOI: 10.1093/eurheartj/ehx646] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/07/2017] [Accepted: 10/20/2017] [Indexed: 12/25/2022] Open
Abstract
Aims Investigators have proposed that cardiovascular magnetic resonance (CMR) should have restrictions similar to those of ionizing imaging techniques. We aimed to investigate the acute effect of 1.5 T CMR on leucocyte DNA integrity, cell counts, and function in vitro, and in a large cohort of patients in vivo. Methods and results In vitro study: peripheral blood mononuclear cells (PBMCs) were isolated from healthy volunteers, and histone H2AX phosphorylation (γ-H2AX) expression, leucocyte counts, and functional parameters were quantified using flow cytometry under the following conditions: (i) immediately following PBMC isolation, (ii) after standing on the benchside as a temperature and time control, (iii) after a standard CMR scan. In vivo study: blood samples were taken from 64 consecutive consenting patients immediately before and after a standard clinical scan. Samples were analysed for γ-H2AX expression and leucocyte counts. CMR was not associated with a significant change in γ-H2AX expression in vitro or in vivo, although there were significant inter-patient variations. In vitro cell integrity and function did not change with CMR. There was a significant reduction in circulating T cells in vivo following CMR. Conclusion 1.5 T CMR was not associated with DNA damage in vitro or in vivo. Histone H2AX phosphorylation expression varied markedly between individuals; therefore, small studies using γ-H2AX as a marker of DNA damage should be interpreted with caution. Cardiovascular magnetic resonance was not associated with loss of leucocyte viability or function in vitro. Cardiovascular magnetic resonance was associated with a statistically significant reduction in viable leucocytes in vivo.
Collapse
Affiliation(s)
- William R Critchley
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.,The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Anna Reid
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK.,Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK
| | - Julie Morris
- Department of Medical Statistics, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Josephine H Naish
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK
| | - John P Stone
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.,The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Alexandra L Ball
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.,The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Triin Major
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.,The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - David Clark
- Wythenshawe Alliance Medical Cardiac MRI Unit, Wythenshawe Hospital, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Nick Waldron
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Christien Fortune
- Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK
| | - Jakub Lagan
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK.,Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK
| | - Gavin A Lewis
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK.,Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK
| | - Mark Ainslie
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Erik B Schelbert
- Department of Medicine, University of Pittsburgh School of Medicine, 3550 Terrace St, Pittsburgh, PA 15213, USA.,Cardiovascular Magnetic Resonance Center, UPMC, 200 Lothrop St., Pittsburgh, PA 15213, USA
| | - Daniel M Davis
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK
| | - Matthias Schmitt
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - James E Fildes
- Manchester Collaborative Centre for Inflammation Research (MCCIR), Division of Infection, Immunity and Respiratory Research, School of Biology, Medicine and Health, Manchester Academic Health Science Centre, Room 2.12 Core Technology Facility, Grafton Street, University of Manchester, M13 9NT Manchester, UK.,The Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK
| | - Christopher A Miller
- North West Heart Centre, Manchester University Hospitals NHS Foundation Trust, Southmoor Road, Wythenshawe, M23 9LT Manchester, UK.,Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, 3rd Floor-Core Technology Facility, 46 Grafton Street, M13 9PL Manchester UK.,Wellcome Centre for Cell-Matrix Research, Division of Cell-Matrix Biology and Regenerative Medicine, School of Biology, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, M13 9PT Manchester, UK
| |
Collapse
|
6
|
Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, Schmitter S, Speck O, Straub S, Zaiss M. Pros and cons of ultra-high-field MRI/MRS for human application. PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 2018; 109:1-50. [PMID: 30527132 DOI: 10.1016/j.pnmrs.2018.06.001] [Citation(s) in RCA: 264] [Impact Index Per Article: 44.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2018] [Revised: 06/06/2018] [Accepted: 06/07/2018] [Indexed: 05/08/2023]
Abstract
Magnetic resonance imaging and spectroscopic techniques are widely used in humans both for clinical diagnostic applications and in basic research areas such as cognitive neuroimaging. In recent years, new human MR systems have become available operating at static magnetic fields of 7 T or higher (≥300 MHz proton frequency). Imaging human-sized objects at such high frequencies presents several challenges including non-uniform radiofrequency fields, enhanced susceptibility artifacts, and higher radiofrequency energy deposition in the tissue. On the other side of the scale are gains in signal-to-noise or contrast-to-noise ratio that allow finer structures to be visualized and smaller physiological effects to be detected. This review presents an overview of some of the latest methodological developments in human ultra-high field MRI/MRS as well as associated clinical and scientific applications. Emphasis is given to techniques that particularly benefit from the changing physical characteristics at high magnetic fields, including susceptibility-weighted imaging and phase-contrast techniques, imaging with X-nuclei, MR spectroscopy, CEST imaging, as well as functional MRI. In addition, more general methodological developments such as parallel transmission and motion correction will be discussed that are required to leverage the full potential of higher magnetic fields, and an overview of relevant physiological considerations of human high magnetic field exposure is provided.
Collapse
Affiliation(s)
- Mark E Ladd
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine, University of Heidelberg, Heidelberg, Germany; Faculty of Physics and Astronomy, University of Heidelberg, Heidelberg, Germany; Erwin L. Hahn Institute for MRI, University of Duisburg-Essen, Essen, Germany.
| | - Peter Bachert
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Physics and Astronomy, University of Heidelberg, Heidelberg, Germany.
| | - Martin Meyerspeer
- Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; MR Center of Excellence, Medical University of Vienna, Vienna, Austria.
| | - Ewald Moser
- Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria; MR Center of Excellence, Medical University of Vienna, Vienna, Austria.
| | - Armin M Nagel
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
| | - David G Norris
- Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Nijmegen, Netherlands; Erwin L. Hahn Institute for MRI, University of Duisburg-Essen, Essen, Germany.
| | - Sebastian Schmitter
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Physikalisch-Technische Bundesanstalt (PTB), Braunschweig and Berlin, Germany.
| | - Oliver Speck
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; German Center for Neurodegenerative Diseases, Magdeburg, Germany; Center for Behavioural Brain Sciences, Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany.
| | - Sina Straub
- Medical Physics in Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
| | - Moritz Zaiss
- High-Field Magnetic Resonance Center, Max-Planck-Institute for Biological Cybernetics, Tübingen, Germany.
| |
Collapse
|
7
|
Friebe B, Godenschweger F, Fatahi M, Speck O, Roggenbuck D, Reinhold D, Reddig A. The potential toxic impact of different gadolinium-based contrast agents combined with 7-T MRI on isolated human lymphocytes. Eur Radiol Exp 2018; 2:40. [PMID: 30483972 PMCID: PMC6258802 DOI: 10.1186/s41747-018-0069-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2018] [Accepted: 10/09/2018] [Indexed: 11/10/2022] Open
Abstract
Background To investigate a potentially amplifying genotoxic or cytotoxic effect of different gadolinium-based contrast agents (GBCAs) in combination with ultra-high-field 7-T magnetic resonance imaging (MRI) exposure in separated human peripheral blood lymphocytes. Methods This in vitro study was approved by the local ethics committee and written informed consent was obtained from all participants. Isolated lymphocytes from twelve healthy donors were incubated with gadobutrol, gadoterate meglumine, gadodiamide, gadopentetate dimeglumine, or gadoxetate either alone or combined with 7-T MRI (1 h). Deoxyribonucleic acid (DNA) double-strand breaks were assessed 15 min after MRI exposure by automated γH2AX foci quantification. Cytotoxicity was determined at later endpoints by Annexin V/propidium iodide apoptosis assay (24 h) and [3H]-thymidine proliferation test (72 h). As a reference, lymphocytes from four different donors were exposed analogously to iodinated contrast agents (iomeprol, iopromide) in combination with computed tomography. Results Baseline γH2AX levels (0.08 ± 0.02 foci/cell) were not significantly (p between 0.135 and 1.000) enhanced after administration of GBCAs regardless of MRI exposure. In contrast to the two investigated macrocyclic GBCAs, lymphocytes exposed to the three linear GBCAs showed a dose-dependent increase in apoptosis (maximum 186% of unexposed control, p < 0.001) and reduced proliferation rate (minimum 0.7% of unexposed control, p < 0.001). However, additional 7-T MRI co-exposure did not alter GBCA-induced cytotoxicity. Conclusions Exposure of lymphocytes to different GBCAs did not reveal significant induction of γH2AX foci, and enhanced cytotoxicity was only observed in lymphocytes treated with the linear GBCAs used in this study, independent of additional 7-T MRI co-exposure. Electronic supplementary material The online version of this article (10.1186/s41747-018-0069-y) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Björn Friebe
- Department of Radiology and Nuclear Medicine, Otto von Guericke University Magdeburg, 39120, Magdeburg, Germany
| | - Frank Godenschweger
- Department of Biomedical Magnetic Resonance, Otto von Guericke University Magdeburg, 39120, Magdeburg, Germany
| | - Mahsa Fatahi
- Department of Biomedical Magnetic Resonance, Otto von Guericke University Magdeburg, 39120, Magdeburg, Germany
| | - Oliver Speck
- Department of Biomedical Magnetic Resonance, Otto von Guericke University Magdeburg, 39120, Magdeburg, Germany.,Leibniz Institute for Neurobiology, 39118, Magdeburg, Germany.,Center for Behavioral Brain Sciences, Otto von Guericke University Magdeburg, 39118, Magdeburg, Germany.,German Center for Neurodegenerative Disease, Site Magdeburg, 39120, Magdeburg, Germany
| | - Dirk Roggenbuck
- Medipan GmbH, 15827, Dahlewitz, Berlin, Germany.,Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, 01958, Senftenberg, Germany
| | - Dirk Reinhold
- Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany
| | - Annika Reddig
- Institute of Molecular and Clinical Immunology, Otto von Guericke University Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
| |
Collapse
|
8
|
Yamaguchi-Sekino S, Kira T, Sekino M, Akahane M. Effects of 7 T static magnetic fields on the expression of biological markers and the formation of bone in rats. Bioelectromagnetics 2018; 40:16-26. [PMID: 30466173 DOI: 10.1002/bem.22161] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2018] [Accepted: 10/26/2018] [Indexed: 01/14/2023]
Abstract
In this study, we aimed to evaluate the effects of 7 T static magnetic fields (SMFs) on rat mesenchymal stem cells (MSCs) in order to determine whether strong SMFs affected the osteogenesis of MSCs. MSCs were prepared from bone marrow cells obtained from the femurs of 7-week-old male Fischer 344 rats. MSCs were then combined with β-tricalcium phosphate (β-TCP), yielding two types of TCP/MSC constructs (TCP/P-1 and P-2) on day 0. Exposure was performed for 3 h/day for 6 days, and the experiments were performed twice using different exposure apparatus (cryovials or 4-well chambers) for each experiment. The results from gene expression, protein expression, and histological analyses showed no reproducible effects on both TCP/P-1 and TCP/P-2 MSC constructs, although osteocalcin levels for TCP/P-1 MSC constructs increased significantly once after 7 T exposure in two experiments. These findings contribute to understanding the effects of strong SMFs on MSC and osteoblasts. Bioelectromagnetics. 40:16-26, 2019. © 2018 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
| | - Tsutomu Kira
- Department of Orthopedic Surgery, Nara Medical University, Kashihara, Japan
| | - Masaki Sekino
- Department of Electrical Engineering and Information Systems, School of Engineering, University of Tokyo, Tokyo, Japan
| | - Manabu Akahane
- Department of Public Health, Health Management and Policy, Nara Medical University School of Medicine, Kashihara, Japan
| |
Collapse
|
9
|
McDonald JS, McDonald RJ, Ekins JB, Tin AS, Costes S, Hudson TM, Schroeder DJ, Kallmes K, Kaufmann SH, Young PM, Lu A, Kadirvel R, Kallmes DF. Gadolinium-enhanced cardiac MR exams of human subjects are associated with significant increases in the DNA repair marker 53BP1, but not the damage marker γH2AX. PLoS One 2018; 13:e0190890. [PMID: 29309426 PMCID: PMC5757995 DOI: 10.1371/journal.pone.0190890] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Accepted: 12/21/2017] [Indexed: 12/13/2022] Open
Abstract
Magnetic resonance imaging is considered low risk, yet recent studies have raised a concern of potential damage to DNA in peripheral blood leukocytes. This prospective Institutional Review Board-approved study examined potential double-strand DNA damage by analyzing changes in the DNA damage and repair markers γH2AX and 53BP1 in patients who underwent a 1.5 T gadolinium-enhanced cardiac magnetic resonance (MR) exam. Sixty patients were enrolled (median age 55 years, 39 males). Patients with history of malignancy or who were receiving chemotherapy, radiation therapy, or steroids were excluded. MR sequence data were recorded and blood samples obtained immediately before and after MR exposure. An automated immunofluorescence assay quantified γH2AX or 53BP1 foci number in isolated peripheral blood mononuclear cells. Changes in foci number were analyzed using the Wilcoxon signed-rank test. Clinical and MR procedural characteristics were compared between patients who had a >10% increase in γH2AX or 53BP1 foci numbers and patients who did not. The number of γH2AX foci did not significantly change following cardiac MR (median foci per cell pre-MR = 0.11, post-MR = 0.11, p = .90), but the number of 53BP1 foci significantly increased following MR (median foci per cell pre-MR = 0.46, post-MR = 0.54, p = .0140). Clinical and MR characteristics did not differ significantly between patients who had at least a 10% increase in foci per cell and those who did not. We conclude that MR exposure leads to a small (median 25%) increase in 53BP1 foci, however the clinical relevance of this increase is unknown and may be attributable to normal variation instead of MR exposure.
Collapse
Affiliation(s)
- Jennifer S. McDonald
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
- * E-mail:
| | - Robert J. McDonald
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Jacob B. Ekins
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Anthony S. Tin
- Exogen Biotechnology Inc., Berkeley, CA, United States of America
| | - Sylvain Costes
- Exogen Biotechnology Inc., Berkeley, CA, United States of America
| | - Tamara M. Hudson
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Dana J. Schroeder
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Kevin Kallmes
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Scott H. Kaufmann
- Department of Molecular Pharmacology and Experimental Therapeutics, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
- Department of Oncology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Philip M. Young
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Aiming Lu
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - Ramanathan Kadirvel
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| | - David F. Kallmes
- Department of Radiology, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
- Department of Neuroscience, College of Medicine, Mayo Clinic, Rochester, MN, United States of America
| |
Collapse
|
10
|
Fasshauer M, Krüwel T, Zapf A, Stahnke VC, Rave-Fränk M, Staab W, Sohns JM, Steinmetz M, Unterberg-Buchwald C, Schuster A, Ritter C, Lotz J. Absence of DNA double-strand breaks in human peripheral blood mononuclear cells after 3 Tesla magnetic resonance imaging assessed by γH2AX flow cytometry. Eur Radiol 2017; 28:1149-1156. [DOI: 10.1007/s00330-017-5056-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2017] [Revised: 08/19/2017] [Accepted: 09/04/2017] [Indexed: 12/15/2022]
|
11
|
Fatahi M, Reddig A, Friebe B, Reinhold D, Speck O. MRI and Genetic Damage: An Update. CURRENT RADIOLOGY REPORTS 2017. [DOI: 10.1007/s40134-017-0216-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
|
12
|
Foster KR, Moulder JE, Budinger TF. Will an MRI Examination Damage Your Genes? Radiat Res 2017; 187:1-6. [DOI: 10.1667/rr14529.1] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
13
|
Hill MA, O'Neill P, McKenna WG. Comments on potential health effects of MRI-induced DNA lesions: quality is more important to consider than quantity. Eur Heart J Cardiovasc Imaging 2016; 17:1230-1238. [PMID: 27550664 PMCID: PMC5081138 DOI: 10.1093/ehjci/jew163] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2016] [Accepted: 07/13/2016] [Indexed: 01/01/2023] Open
Abstract
Magnetic resonance imaging (MRI) is increasingly being used in cardiology to detect heart disease and guide therapy. It is mooted to be a safer alternative to imaging techniques, such as computed tomography (CT) or coronary angiographic imaging. However, there has recently been an increased interest in the potential long-term health risks of MRI, especially in the light of the controversy resulting from a small number of research studies reporting an increase in DNA damage following exposure, with calls to limit its use and avoid unnecessary examination, according to the precautionary principle. Overall the published data are somewhat limited and inconsistent; the ability of MRI to produce DNA lesions has yet to be robustly demonstrated and future experiments should be carefully designed to optimize sensitivity and benchmarked to validate and assess reproducibility. The majority of the current studies have focussed on the initial induction of DNA damage, and this has led to comparisons between the reported induction of γH2AX and implied double-strand break (DSB) yields produced following MRI with induction by imaging techniques using ionizing radiation. However, γH2AX is not only a marker of classical double-ended DSB, but also a marker of stalled replication forks and in certain circumstances stalled DNA transcription. Additionally, ionizing radiation is efficient at producing complex DNA damage, unique to ionizing radiation, with an associated reduction in repairability. Even if the fields associated with MRI are capable of producing DNA damage, the lesions produced will in general be simple, similar to those produced by endogenous processes. It is therefore inappropriate to try and infer cancer risk by simply comparing the yields of γH2AX foci or DNA lesions potentially produced by MRI to those produced by a given exposure of ionizing radiation, which will generally be more biologically effective and have a greater probability of leading to long-term health effects. As a result, it is important to concentrate on more relevant downstream end points (e.g. chromosome aberration production), along with potential mechanisms by which MRI may lead to DNA lesions. This could potentially involve a perturbation in homeostasis of oxidative stress, modifying the background rate of endogenous DNA damage induction. In summary, what the field needs at the moment is more research and less fear mongering.
Collapse
Affiliation(s)
- M A Hill
- CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Gray Laboratories, ORCRB Roosevelt Drive, Oxford OX3 7DQ, UK
| | - P O'Neill
- CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Gray Laboratories, ORCRB Roosevelt Drive, Oxford OX3 7DQ, UK
| | - W G McKenna
- CRUK/MRC Oxford Institute for Radiation Oncology, University of Oxford, Gray Laboratories, ORCRB Roosevelt Drive, Oxford OX3 7DQ, UK
| |
Collapse
|
14
|
Reddig A, Fatahi M, Roggenbuck D, Ricke J, Reinhold D, Speck O, Friebe B. Impact of in Vivo High-Field-Strength and Ultra-High-Field-Strength MR Imaging on DNA Double-Strand-Break Formation in Human Lymphocytes. Radiology 2016; 282:782-789. [PMID: 27689924 DOI: 10.1148/radiol.2016160794] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Purpose To determine the impact of different magnetic field strengths (1, 1.5, 3, and 7 T) and the effect of contrast agent on DNA double-strand-break (DSB) formation in patients undergoing magnetic resonance (MR) imaging. Materials and Methods This in vivo study was approved by the local ethics committee, and written informed consent was obtained from each patient. To analyze the level of DNA DSBs, peripheral blood mononuclear cells were isolated from blood samples drawn directly before, as well as 5 minutes and 30 minutes after MR imaging examination. After performing γH2AX immunofluorescence staining, DSBs were quantified with automated digital microscopy. MR group consisted of 43 patients (22 women, 21 men; mean age, 46.1 years; range, 20-77 years) and was further subdivided according to the applied field strength and administration of contrast agent. Additionally, 10 patients undergoing either unenhanced or contrast material-enhanced computed tomography (CT) served as positive control subjects. Statistical analysis was performed with Friedman test. Results Whereas DSBs in lymphocytes increased after CT exposure (before MR imaging: 0.14 foci per cell ± 0.05; 5 minutes after: 0.26 foci per cell ± 0.07; 30 minutes after: 0.24 foci per cell ± 0.07; P ≤ .05), no alterations were observed in patients examined with MR imaging (before MR imaging: 0.13 foci per cell ± 0.02; 5 minutes after: 0.12 foci per cell ± 0.02; 30 minutes after: 0.11 foci per cell ± 0.02; P > .05). Differentiated analysis of MR imaging subgroups again revealed no significant changes in γH2AX level. Conclusion Analysis of γH2AX foci showed no evidence of DSB induction after MR examination, independent of the applied field strength and administration of gadolinium-based contrast agent.
Collapse
Affiliation(s)
- Annika Reddig
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Mahsa Fatahi
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Dirk Roggenbuck
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Jens Ricke
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Dirk Reinhold
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Oliver Speck
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| | - Björn Friebe
- From the Institute of Molecular and Clinical Immunology (A.R., D. Reinhold); Department of Biomedical Magnetic Resonance (M.F., O.S.); and Department of Radiology and Nuclear Medicine (J.R., B.F.), Otto von Guericke University Magdeburg, Leipziger Str 44, 39120 Magdeburg, Germany; Medipan, Berlin, Germany (D. Roggenbuck); Institute of Biotechnology, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany (D. Roggenbuck); Leibniz Institute for Neurobiology, Magdeburg, Germany (O.S.); Center for Behavioral Brain Sciences, Magdeburg, Germany (O.S.); and German Center for Neurodegenerative Disease, Site Magdeburg, Magdeburg, Germany (O.S.)
| |
Collapse
|
15
|
[Clinical cardiac MRI investigations with established protocols : No increased rate of DNA double-strand breaks]. Radiologe 2016; 56:663-4. [PMID: 27422259 DOI: 10.1007/s00117-016-0145-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
DNA double-strand breaks and micronuclei in human blood lymphocytes after repeated whole body exposures to 7T Magnetic Resonance Imaging. Neuroimage 2016; 133:288-293. [DOI: 10.1016/j.neuroimage.2016.03.023] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2016] [Revised: 03/10/2016] [Accepted: 03/11/2016] [Indexed: 12/13/2022] Open
|
17
|
Lancellotti P, Nchimi A, Delierneux C, Hego A, Gosset C, Gothot A, Jean-Flory Tshibanda L, Oury C. Biological Effects of Cardiac Magnetic Resonance on Human Blood Cells. Circ Cardiovasc Imaging 2015; 8:e003697. [PMID: 26338876 DOI: 10.1161/circimaging.115.003697] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND Cardiac magnetic resonance (CMR) is increasingly used for the diagnosis and management of cardiac diseases. Recent studies have reported immediate post-CMR DNA double-strand breaks in T lymphocytes. We sought to evaluate CMR-induced DNA damage in lymphocytes, alterations of blood cells, and their temporal persistence. METHODS AND RESULTS In 20 prospectively enrolled healthy men (31.4±7.9 years), blood was drawn before and after (1-2 hours, 2 days, 1 month, and 1 year) unenhanced 1.5T CMR. Blood cell counts, cell death, and activation status of lymphocytes, monocytes, neutrophils, and platelets were evaluated. The first 2-hour post-CMR were characterized by a small increase of lymphocyte B and neutrophil counts and a transient drop of total lymphocytes because of a decrease in natural killer cells. Among blood cells, only neutrophils and monocytes displayed slight and transient activation. DNA double-strand breaks in lymphocytes were quantified through flow cytometric analysis of H2AX phosphorylation (γ-H2AX). γ-H2AX intensity in T lymphocytes did not change early after CMR but increased significantly at day 2 ≤1 month before returning to baseline levels of 1-year post-CMR. CONCLUSIONS Unenhanced CMR is associated with minor but significant immediate blood cell alterations or activations figuring inflammatory response, as well as DNA damage in T lymphocytes observed from day 2 until the first month but disappearing at 1-year follow-up. Although further studies are required to definitely state whether CMR can be used safely, our findings already call for caution when it comes to repeat this examination within a month.
Collapse
Affiliation(s)
- Patrizio Lancellotti
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.).
| | - Alain Nchimi
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Céline Delierneux
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Alexandre Hego
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Christian Gosset
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - André Gothot
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Luaba Jean-Flory Tshibanda
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| | - Cécile Oury
- From the Department of Cardiology and Radiology, GIGA-Cardiovascular Sciences (P.L., A.N., C.D., A.H., A.G., L.J.-F.T., C.O.) and Hematology Department, University Hospital Sart Tilman (C.G., A.G.), University of Liège, Liège, Belgium; and Gruppo Villa Maria Care and Research, E.S. Health Science Foundation, Lugo (RA), Italy (P.L.)
| |
Collapse
|
18
|
Brand M, Ellmann S, Sommer M, May MS, Eller A, Wuest W, Engert C, Achenbach S, Kuefner MA, Baeuerle T, Lell M, Uder M. Influence of Cardiac MR Imaging on DNA Double-Strand Breaks in Human Blood Lymphocytes. Radiology 2015. [PMID: 26225451 DOI: 10.1148/radiol.2015150555] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
PURPOSE To evaluate the ability of magnetic resonance (MR) imaging to induce deoxyribonucleic acid (DNA) damage in patients who underwent cardiac MR imaging in daily routine by using γ-H2AX immunofluorescence microscopy. MATERIALS AND METHODS This study complies with the Declaration of Helsinki and was performed according to local ethics committee approval. Informed patient consent was obtained. Blood samples from 45 patients (13 women, 32 men; mean age, 50.3 years [age range, 20-89 years]) were obtained before and after contrast agent-enhanced cardiac MR imaging. MR imaging-induced double-strand breaks (DSBs) were quantified in isolated blood lymphocytes by using immunofluorescence microscopy after staining the phosphorylated histone variant γ-H2AX. Twenty-nine patients were examined with a myocarditis protocol (group A), 10 patients with a stress-testing protocol (group B), and six patients with flow measurements and angiography (group C). Paired t test was performed to compare excess foci before and after MR imaging. RESULTS The mean baseline DSB level before MR imaging and 5 minutes after MR imaging was, respectively, 0.116 DSB per cell ± 0.019 (standard deviation) and 0.117 DSB per cell ± 0.019 (P = .71). There was also no significant difference in DSBs in these subgroups (group A: DSB per cell before and after MR imaging, respectively, 0.114 and 0.114, P = .91; group B: DSB per cell before and after MR imaging, respectively, 0.123 and 0.124, P = .78; group C: DSB per cell before and after MR imaging, respectively, 0.114 and 0.115, P = .36). CONCLUSION By using γ-H2AX immunofluorescence microscopy, no DNA DSBs were detected after cardiac MR imaging.
Collapse
Affiliation(s)
- Michael Brand
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Stephan Ellmann
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Matthias Sommer
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Matthias S May
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Achim Eller
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Wolfgang Wuest
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Christina Engert
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Stephan Achenbach
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Michael A Kuefner
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Tobias Baeuerle
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Michael Lell
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| | - Michael Uder
- From the Department of Radiology, University Hospital Erlangen-Nuremberg, Maximiliansplatz 1, D-91054 Erlangen, Germany (M.B., S.E., M.S., M.S.M., A.E., W.W., C.E., M.A.K., T.B., M.L., M.U.); and Department of Cardiology, University Hospital Erlangen-Nuremberg, Erlangen, Germany (S.A.)
| |
Collapse
|
19
|
Reddig A, Fatahi M, Friebe B, Guttek K, Hartig R, Godenschweger F, Roggenbuck D, Ricke J, Reinhold D, Speck O. Analysis of DNA Double-Strand Breaks and Cytotoxicity after 7 Tesla Magnetic Resonance Imaging of Isolated Human Lymphocytes. PLoS One 2015; 10:e0132702. [PMID: 26176601 PMCID: PMC4503586 DOI: 10.1371/journal.pone.0132702] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2015] [Accepted: 06/17/2015] [Indexed: 01/25/2023] Open
Abstract
The global use of magnetic resonance imaging (MRI) is constantly growing and the field strengths increasing. Yet, only little data about harmful biological effects caused by MRI exposure are available and published research analyzing the impact of MRI on DNA integrity reported controversial results. This in vitro study aimed to investigate the genotoxic and cytotoxic potential of 7 T ultra-high-field MRI on isolated human peripheral blood mononuclear cells. Hence, unstimulated mononuclear blood cells were exposed to 7 T static magnetic field alone or in combination with maximum permissible imaging gradients and radiofrequency pulses as well as to ionizing radiation during computed tomography and γ-ray exposure. DNA double-strand breaks were quantified by flow cytometry and automated microscopy analysis of immunofluorescence stained γH2AX. Cytotoxicity was studied by CellTiter-Blue viability assay and [3H]-thymidine proliferation assay. Exposure of unstimulated mononuclear blood cells to 7 T static magnetic field alone or combined with varying gradient magnetic fields and pulsed radiofrequency fields did not induce DNA double-strand breaks, whereas irradiation with X- and γ-rays led to a dose-dependent induction of γH2AX foci. The viability assay revealed a time- and dose-dependent decrease in metabolic activity only among samples exposed to γ-radiation. Further, there was no evidence for altered proliferation response after cells were exposed to 7 T MRI or low doses of ionizing radiation (≤ 0.2 Gy). These findings confirm the acceptance of MRI as a safe non-invasive diagnostic imaging tool, but whether MRI can induce other types of DNA lesions or DNA double-strand breaks during altered conditions still needs to be investigated.
Collapse
Affiliation(s)
- Annika Reddig
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
- * E-mail:
| | - Mahsa Fatahi
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Björn Friebe
- Department of Radiology and Nuclear Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Karina Guttek
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Roland Hartig
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Frank Godenschweger
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Dirk Roggenbuck
- Medipan GmbH, Dahlewitz/Berlin, Germany
- Faculty of Natural Sciences, Brandenburg University of Technology Cottbus-Senftenberg, Senftenberg, Germany
| | - Jens Ricke
- Department of Radiology and Nuclear Medicine, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Dirk Reinhold
- Institute of Molecular and Clinical Immunology, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
| | - Oliver Speck
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany
- Leibniz Institute for Neurobiology, Magdeburg, Germany
- Center for Behavioral Brain Sciences, Magdeburg, Germany
- German Center for Neurodegenerative Disease, Magdeburg, Germany
| |
Collapse
|
20
|
Vijayalaxmi, Fatahi M, Speck O. Magnetic resonance imaging (MRI): A review of genetic damage investigations. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH 2015; 764:51-63. [PMID: 26041266 DOI: 10.1016/j.mrrev.2015.02.002] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/24/2014] [Revised: 02/12/2015] [Accepted: 02/13/2015] [Indexed: 10/24/2022]
Abstract
Magnetic resonance imaging (MRI) is a powerful, non-invasive diagnostic medical imaging technique widely used to acquire detailed information about anatomy and function of different organs in the body, in both health and disease. It utilizes electromagnetic fields of three different frequency bands: static magnetic field (SMF), time-varying gradient magnetic fields (GMF) in the kHz range and pulsed radiofrequency fields (RF) in the MHz range. There have been some investigations examining the extent of genetic damage following exposure of bacterial and human cells to all three frequency bands of electromagnetic fields, as used during MRI: the rationale for these studies is the well documented evidence of positive correlation between significantly increased genetic damage and carcinogenesis. Overall, the published data were not sufficiently informative and useful because of the small sample size, inappropriate comparison of experimental groups, etc. Besides, when an increased damage was observed in MRI-exposed cells, the fate of such lesions was not further explored from multiple 'down-stream' events. This review provides: (i) information on the basic principles used in MRI technology, (ii) detailed experimental protocols, results and critical comments on the genetic damage investigations thus far conducted using MRI equipment and, (iii) a discussion on several gaps in knowledge in the current scientific literature on MRI. Comprehensive, international, multi-centered collaborative studies, using a common and widely used MRI exposure protocol (cardiac or brain scan) incorporating several genetic/epigenetic damage end-points as well as epidemiological investigations, in large number of individuals/patients are warranted to reduce and perhaps, eliminate uncertainties raised in genetic damage investigations in cells exposed in vitro and in vivo to MRI.
Collapse
Affiliation(s)
- Vijayalaxmi
- Department of Radiology, University of Texas Health Science Center, San Antonio, United States
| | - Mahsa Fatahi
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
| | - Oliver Speck
- Department of Biomedical Magnetic Resonance, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany; German Center for Neurodegenerative Disease (DZNE) Site, Magdeburg, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany; Center for Behavioral Brain Sciences, Magdeburg, Germany
| |
Collapse
|
21
|
Gaibazzi N, Marziliano N, Porter TR, Negri G, Demola MA, Reverberi C, Ardissino D. Assessment of DNA damage associated with standard or contrast diagnostic echocardiography. Int J Cardiol 2015; 180:96-9. [PMID: 25438226 DOI: 10.1016/j.ijcard.2014.11.140] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/08/2014] [Accepted: 11/22/2014] [Indexed: 11/17/2022]
Affiliation(s)
- Nicola Gaibazzi
- Cardiology Department, Parma University Hospital, Parma, Italy.
| | - Nicola Marziliano
- Cardiology Department, Parma University Hospital, Parma, Italy; Health Sciences Department, University of Campobasso, Campobasso Italy
| | - Thomas R Porter
- Section of Cardiology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA
| | - Gianmarco Negri
- Cardiology Department, Parma University Hospital, Parma, Italy
| | | | | | - Diego Ardissino
- Cardiology Department, Parma University Hospital, Parma, Italy
| |
Collapse
|
22
|
Bioeffects of static magnetic fields: oxidative stress, genotoxic effects, and cancer studies. BIOMED RESEARCH INTERNATIONAL 2013; 2013:602987. [PMID: 24027759 PMCID: PMC3763575 DOI: 10.1155/2013/602987] [Citation(s) in RCA: 109] [Impact Index Per Article: 9.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 04/24/2013] [Revised: 07/11/2013] [Accepted: 07/11/2013] [Indexed: 01/24/2023]
Abstract
The interaction of static magnetic fields (SMFs) with living organisms is a rapidly growing field of investigation. The magnetic fields (MFs) effect observed with radical pair recombination is one of the well-known mechanisms by which MFs interact with biological systems. Exposure to SMF can increase the activity, concentration, and life time of paramagnetic free radicals, which might cause oxidative stress, genetic mutation, and/or apoptosis. Current evidence suggests that cell proliferation can be influenced by a treatment with both SMFs and anticancer drugs. It has been recently found that SMFs can enhance the anticancer effect of chemotherapeutic drugs; this may provide a new strategy for cancer therapy. This review focuses on our own data and other data from the literature of SMFs bioeffects. Three main areas of investigation have been covered: free radical generation and oxidative stress, apoptosis and genotoxicity, and cancer. After an introduction on SMF classification and medical applications, the basic phenomena to understand the bioeffects are described. The scientific literature is summarized, integrated, and critically analyzed with the help of authoritative reviews by recognized experts; international safety guidelines are also cited.
Collapse
|
23
|
Loja T, Stehlikova O, Palko L, Vrba K, Rampl I, Klabusay M. Influence of pulsed electromagnetic and pulsed vector magnetic potential field on the growth of tumor cells. Electromagn Biol Med 2013; 33:190-7. [PMID: 23781986 DOI: 10.3109/15368378.2013.800104] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
AIMS AND BACKGROUND Tumor diseases cause 20% of deaths in Europe and they are the second most common cause of death and morbidity after cardiovascular diseases. Thus, tumor cells are target of many therapeutic strategies and tumor research is focused on searching more efficient and specific drugs as well as new therapeutic approaches. One of the areas of tumor research is an issue of external fields. In our work, we tested influence of a pulsed electromagnetic field (PEMF) and a hypothetic field of the pulsed vector magnetic potential (PVMP) on the growth of tumor cells; and further the possible growth inhibition effect of the PVMP. METHODS Both unipolar and bipolar PEMF fields of 5 mT and PVMP fields of 0 mT at frequencies of 15 Hz, 125 Hz and 625 Hz were tested on cancer cell lines derived from various types of tumors: CEM/C2 (acute lymphoblastic leukemia), SU-DHL-4 (B-cell lymphoma), COLO-320DM (colorectal adenocarcinoma), MDA-BM-468 (breast adenocarcinoma), and ZR-75-1 (ductal carcinoma). Cell morphology was observed, proliferation activity using WST assay was measured and simultaneous proportion of live, early apoptotic and dead cells was detected using flow cytometry. RESULTS A PEMF of 125 Hz and 625 Hz for 24 h-48 h increased proliferation activity in the 2 types of cancer cell lines used, i.e. COLO-320DM and ZR-75-1. In contrast, any of employed methods did not confirm a significant inhibitory effect of hypothetic PVMP field on tumor cells.
Collapse
Affiliation(s)
- Tomas Loja
- Masaryk Memorial Cancer Institute , Brno , Czech Republic
| | | | | | | | | | | |
Collapse
|
24
|
Alternative splicing of CHEK2 and codeletion with NF2 promote chromosomal instability in meningioma. Neoplasia 2012; 14:20-8. [PMID: 22355270 DOI: 10.1593/neo.111574] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2011] [Revised: 12/23/2011] [Accepted: 01/03/2012] [Indexed: 12/13/2022] Open
Abstract
Mutations of the NF2 gene on chromosome 22q are thought to initiate tumorigenesis in nearly 50% of meningiomas, and 22q deletion is the earliest and most frequent large-scale chromosomal abnormality observed in these tumors. In aggressive meningiomas, 22q deletions are generally accompanied by the presence of large-scale segmental abnormalities involving other chromosomes, but the reasons for this association are unknown. We find that large-scale chromosomal alterations accumulate during meningioma progression primarily in tumors harboring 22q deletions, suggesting 22q-associated chromosomal instability. Here we show frequent codeletion of the DNA repair and tumor suppressor gene, CHEK2, in combination with NF2 on chromosome 22q in a majority of aggressive meningiomas. In addition, tumor-specific splicing of CHEK2 in meningioma leads to decreased functional Chk2 protein expression. We show that enforced Chk2 knockdown in meningioma cells decreases DNA repair. Furthermore, Chk2 depletion increases centrosome amplification, thereby promoting chromosomal instability. Taken together, these data indicate that alternative splicing and frequent codeletion of CHEK2 and NF2 contribute to the genomic instability and associated development of aggressive biologic behavior in meningiomas.
Collapse
|
25
|
Fan G, Wen L, Li M, Li C, Luo B, Wang F, Zhou L, Liu L. Isolation of mouse mesenchymal stem cells with normal ploidy from bone marrows by reducing oxidative stress in combination with extracellular matrix. BMC Cell Biol 2011; 12:30. [PMID: 21729331 PMCID: PMC3141734 DOI: 10.1186/1471-2121-12-30] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2011] [Accepted: 07/06/2011] [Indexed: 01/02/2023] Open
Abstract
BACKGROUND Isolation of mouse MSCs (mMSCs) with normal ploidy from bone marrow remains challenging. mMSCs isolated under 20% O(2) are frequently contaminated by overgrown hematopoietic cells, and could also be especially vulnerable to oxidative damage, resulting in chromosomal instability. Culture under low oxygen or extracellular matrix (ECM) improves proliferation of MSCs in several species. We tested the hypothesis that culture under low oxygen in combination with ECM prepared from mouse embryonic fibroblast (MEF-ECM) could be used to purify proliferative mMSCs, and to reduce oxidative damage and maintain their chromosomal stability. RESULTS Optimization of culture conditions under 20% O(2) resulted in immortalization of mMSCs, showing extensive chromosome abnormalities, consistent with previous studies. In contrast, culture under low oxygen (2% O(2)) improved proliferation of mMSCs and reduced oxidative damage, such that mMSCs were purified simply by plating at low density under 2% O(2). MEF-ECM reduced oxidative damage and enhanced proliferation of mMSCs. However, these isolated mMSCs still exhibited high frequency of chromosome abnormalities, suggesting that low oxygen or in combination with MEF-ECM was insufficient to fully protect mMSCs from oxidative damage. Notably, antioxidants (alpha -phenyl-t-butyl nitrone (PBN) and N-acetylcysteine (NAC)) further reduced DNA damage and chromosomal abnormalities, and increased proliferation of mMSCs. mMSCs isolated by the combination method were successfully used to generate induced pluripotent stem (iPS) cells by ectopic expression of Oct4, Sox2, Klf4 and c-Myc. CONCLUSIONS We have developed a technique that allows to reduce the number of karyotypic abnormalities for isolation of primary mMSCs and for limited culture period by combination of low oxygen, MEF-ECM, antioxidants and low density plating strategy. The effectiveness of the new combination method is demonstrated by successful generation of iPS cells from the isolated mMSCs. However, a culture system for mMSCs still is needed to prevent all the anomalies, especially after a long-term culture period.
Collapse
Affiliation(s)
- Guokuan Fan
- School of Life Science, Sun Yat-Sen University, Guangzhou, China
| | | | | | | | | | | | | | | |
Collapse
|
26
|
Lee JW, Kim MS, Kim YJ, Choi YJ, Lee Y, Chung HW. Genotoxic effects of 3 T magnetic resonance imaging in cultured human lymphocytes. Bioelectromagnetics 2011; 32:535-42. [PMID: 21412810 DOI: 10.1002/bem.20664] [Citation(s) in RCA: 44] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2010] [Accepted: 02/14/2011] [Indexed: 01/07/2023]
Abstract
The clinical and preclinical use of high-field intensity (HF, 3 T and above) magnetic resonance imaging (MRI) scanners have significantly increased in the past few years. However, potential health risks are implied in the MRI and especially HF MRI environment due to high-static magnetic fields, fast gradient magnetic fields, and strong radiofrequency electromagnetic fields. In this study, the genotoxic potential of 3 T clinical MRI scans in cultured human lymphocytes in vitro was investigated by analyzing chromosome aberrations (CA), micronuclei (MN), and single-cell gel electrophoresis. Human lymphocytes were exposed to electromagnetic fields generated during MRI scanning (clinical routine brain examination protocols: three-channel head coil) for 22, 45, 67, and 89 min. We observed a significant increase in the frequency of single-strand DNA breaks following exposure to a 3 T MRI. In addition, the frequency of both CAs and MN in exposed cells increased in a time-dependent manner. The frequencies of MN in lymphocytes exposed to complex electromagnetic fields for 0, 22, 45, 67, and 89 min were 9.67, 11.67, 14.67, 18.00, and 20.33 per 1000 cells, respectively. Similarly, the frequencies of CAs in lymphocytes exposed for 0, 45, 67, and 89 min were 1.33, 2.33, 3.67, and 4.67 per 200 cells, respectively. These results suggest that exposure to 3 T MRI induces genotoxic effects in human lymphocytes.
Collapse
Affiliation(s)
- Joong Won Lee
- Graduate School of Public Health, Seoul National University, Gwanak-gu, Seoul, Republic of Korea
| | | | | | | | | | | |
Collapse
|